FDA.reportPublic FDA data

Albuminex 250 MG/ML per 50 ML Injection

RxCUI
2054170
RxNorm name
Albuminex 250 MG/ML per 50 ML Injection
Display name
Albuminex 250 MG/ML per 50 ML Injection
Full name
Albuminex 250 MG/ML per 50 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125644AlbuminexAlbumin (Human)-kjda351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BEIZRAYDOCETAXELZydus Pharmaceuticals USA Inc.8fb7d980-d6c7-468b-a9f0-adff16101a4b2025-12-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2054170
ALBUMINEXALBUMIN HUMANBPL167f48d0-8ae5-4f7e-b050-9673dad78acc2024-12-31Warnings, Adverse reactionsExact identifier
rxcui: 2054170

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
167f48d0-8ae5-4f7e-b050-9673dad78accAlbuminex 250 MG/ML per 50 ML InjectionSY8These highlights do not include all the information needed to use ALBUMINEX ® 25% Albumin (human) - kjda safely and effectively. See full prescribing information for ALBUMINEX ® 25%. ALBUMINEX ® 25% (human albumin) solution for injection Initial U.S. Approval: [2018]20241231
167f48d0-8ae5-4f7e-b050-9673dad78accAlbuminex 25 % per 50 ML InjectionSY8These highlights do not include all the information needed to use ALBUMINEX ® 25% Albumin (human) - kjda safely and effectively. See full prescribing information for ALBUMINEX ® 25%. ALBUMINEX ® 25% (human albumin) solution for injection Initial U.S. Approval: [2018]20241231
167f48d0-8ae5-4f7e-b050-9673dad78acc50 ML albumin human-kjda 250 MG/ML Injection [Albuminex]SBD8These highlights do not include all the information needed to use ALBUMINEX ® 25% Albumin (human) - kjda safely and effectively. See full prescribing information for ALBUMINEX ® 25%. ALBUMINEX ® 25% (human albumin) solution for injection Initial U.S. Approval: [2018]20241231
167f48d0-8ae5-4f7e-b050-9673dad78accALBUMINEX 25 % in 50 ML InjectionPSN8These highlights do not include all the information needed to use ALBUMINEX ® 25% Albumin (human) - kjda safely and effectively. See full prescribing information for ALBUMINEX ® 25%. ALBUMINEX ® 25% (human albumin) solution for injection Initial U.S. Approval: [2018]20241231
8fb7d980-d6c7-468b-a9f0-adff16101a4bAlbuminex 250 MG/ML per 50 ML InjectionSY4These highlights do not include all the information needed to use BEIZRAY safely and effectively. See full prescribing information for BEIZRAY. BEIZRAY (docetaxel) injection, for intravenous use Initial U.S. Approval: 199620251217
8fb7d980-d6c7-468b-a9f0-adff16101a4bAlbuminex 25 % per 50 ML InjectionSY4These highlights do not include all the information needed to use BEIZRAY safely and effectively. See full prescribing information for BEIZRAY. BEIZRAY (docetaxel) injection, for intravenous use Initial U.S. Approval: 199620251217
8fb7d980-d6c7-468b-a9f0-adff16101a4bALBUMINEX 25 % in 50 ML InjectionPSN4These highlights do not include all the information needed to use BEIZRAY safely and effectively. See full prescribing information for BEIZRAY. BEIZRAY (docetaxel) injection, for intravenous use Initial U.S. Approval: 199620251217
8fb7d980-d6c7-468b-a9f0-adff16101a4b50 ML albumin human-kjda 250 MG/ML Injection [Albuminex]SBD4These highlights do not include all the information needed to use BEIZRAY safely and effectively. See full prescribing information for BEIZRAY. BEIZRAY (docetaxel) injection, for intravenous use Initial U.S. Approval: 199620251217